Amanote Research

Amanote Research

    RegisterSign In

Who Will Benefit From Anticoagulant Therapy? Use of the CHADS2 Score and Its Variants

Research Reports in Clinical Cardiology
doi 10.2147/rrcc.s39091
Full Text
Open PDF
Abstract

Available in full text

Date

April 1, 2014

Authors
Greg FlakerAtul SinglaMayank Mittal
Publisher

Informa UK Limited


Related search

Mexico and the North American Free Trade Agreement: Who Will Benefit?

Choice Reviews Online
1994English

Can Computed Tomographic Angiography Be Used to Predict Who Will Not Benefit From Endovascular Treatment in Patients With Acute Ischemic Stroke? The CTA-ABC Score

Journal of Korean Neurosurgical Society
NeuroscienceSurgeryNeurology
2020English

Who Benefits From Child Benefit?

Economic Inquiry
AccountingManagementEconomicsEconometricsBusiness
2010English

Will Patients Benefit From Regionalization of Gynecologic Cancer Care?

PLoS ONE
Multidisciplinary
2009English

Thrombosis and Anticoagulant Therapy

American Heart Journal
Cardiovascular MedicineCardiology
1962English

Bleeding From Occult Tumors During Anticoagulant Therapy

Circulation
Cardiovascular MedicinePhysiologyCardiology
1962English

V. Indication of Oral Anticoagulant Drugs and Its Use in Clinical Practice

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

The Case for Anticoagulant Therapy

Circulation
Cardiovascular MedicinePhysiologyCardiology
1964English

Who Will Guard the Guardians ?

Nature
Multidisciplinary
1969English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy